<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>RP之光爱心联盟 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-22T11:59:23+08:00</updated>
  <subtitle>rp之光爱心联盟的宗旨是：面向广大视网膜病变患者及其亲友，为他们建设一个交流信息、相互沟通的平台，增进病友间的凝聚力，共同迎接命运的挑战；提供科研、医疗信息，专家咨询等多方面的服务，提升社会对视网膜病变知识的了解与认识。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>重磅通知丨第一期“追光计划”关爱视障者直播论坛即将开启！</title>
    <updated>2021-01-22T10:15:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/BigwcvbTauQtEAl4xzkBTQ</id>
    <link href="https://mp.weixin.qq.com/s/BigwcvbTauQtEAl4xzkBTQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>纽福斯与AAVnerGene就新一代眼科基因治疗AAV载体技术建立全球战略合作伙伴关系</title>
    <updated>2021-01-20T09:22:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/mru93vjLB5YYCNeW-cHmXQ</id>
    <link href="https://mp.weixin.qq.com/s/mru93vjLB5YYCNeW-cHmXQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>RP人作品欣赏——深井一对一</title>
    <updated>2021-01-18T09:31:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/HQogbo_zpkRMPYpSDVT-kw</id>
    <link href="https://mp.weixin.qq.com/s/HQogbo_zpkRMPYpSDVT-kw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ReNeuron视网膜祖细胞治疗RP2a期扩展研究中完成了首个小组治疗</title>
    <updated>2021-01-16T09:55:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/Ml22rKDFukAWKM8rXG9tFQ</id>
    <link href="https://mp.weixin.qq.com/s/Ml22rKDFukAWKM8rXG9tFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第二届RP之光爱心联盟朗诵比赛开始了</title>
    <updated>2021-01-15T13:52:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/e5Zor8OqbXo4_OMKyvubwg</id>
    <link href="https://mp.weixin.qq.com/s/e5Zor8OqbXo4_OMKyvubwg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ProQR完成了RNA治疗 LCA10 的2/3期临床试验的注册</title>
    <updated>2021-01-15T13:52:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/iwVWL_bjWsTT7rVBC0oI5w</id>
    <link href="https://mp.weixin.qq.com/s/iwVWL_bjWsTT7rVBC0oI5w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>隔空对弈虚落子 胸怀韬略见真功——第一届RP之光爱心联盟网络象棋比赛圆满落幕</title>
    <updated>2021-01-12T10:28:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/Fj8ZjCsL6r52ZfAMx16rmQ</id>
    <link href="https://mp.weixin.qq.com/s/Fj8ZjCsL6r52ZfAMx16rmQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>RP人作品欣赏--那年花开她还在</title>
    <updated>2021-01-09T09:53:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/owkq3TlAyFUUkETywgsomQ</id>
    <link href="https://mp.weixin.qq.com/s/owkq3TlAyFUUkETywgsomQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>以色列纳米视网膜研发专家问答</title>
    <updated>2021-01-08T11:22:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/fwoNjo4oFvbacKpRNb1LIg</id>
    <link href="https://mp.weixin.qq.com/s/fwoNjo4oFvbacKpRNb1LIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>``下一个重大步骤&#39;&#39;：T的研究人员致力于治疗视力丧失</title>
    <updated>2021-01-07T10:11:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/YxzacgM2WJA-eqcHyO8lUQ</id>
    <link href="https://mp.weixin.qq.com/s/YxzacgM2WJA-eqcHyO8lUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>在逐渐接近最关键的读数后Biogen选择了一个新的眼科基因治疗合作伙伴</title>
    <updated>2021-01-06T11:21:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/7OuiDRsLDZep-wtLyUCqGA</id>
    <link href="https://mp.weixin.qq.com/s/7OuiDRsLDZep-wtLyUCqGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>